XML 33 R24.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Net Loss per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Net Loss per Share |
Schedule of anti-dilutive common stock equivalents | The following common stock equivalents were excluded from the calculation of diluted net loss per share allocable to common stockholders because their inclusion would have been anti-dilutive:
​ | ​ | ​ | ​ | ​
​ | ​ | For the Three and Nine Months Ended
​ | ​ | September 30,
​ |  | 2022 | ​ | 2021
Unvested restricted stock and restricted stock unit awards |  | 1,503,682 | ​ | 750,456
Outstanding stock options |  | 5,216,124 | ​ | 3,083,415
Total |  | 6,719,806 | ​ | 3,833,871

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration